Scl.Hno
SCL.HNO operates in the construction materials industry, producing and distributing essential materials for infrastructure and building projects.
Business. SCL.HNO operates in the construction materials industry, producing and distributing essential materials for infrastructure and building projects.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
- Macro
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SCL.HNO operates in the construction materials industry, producing and distributing essential materials for infrastructure and building projects.
SCL.HNO has a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company reported negative free cash flow of -11.28 billion and capital expenditures of -110.81 billion, reflecting significant reinvestment in operations.
The company's return on equity of 14.91% and return on assets of 7.33% outperform typical industry benchmarks, indicating strong profitability and efficient asset utilization. These metrics suggest SCL.HNO is generating value for shareholders and effectively deploying its capital base.
SCL.HNO's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which increases exposure to regional economic or regulatory shifts. The company's operating income of 81.23 billion and net income of 64.30 billion highlight its core earnings strength, but the lack of segmental or geographic breakdown limits visibility into growth drivers.
Looking ahead, SCL.HNO is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The company's capital expenditures are expected to remain high, driven by ongoing infrastructure projects and operational expansion.
The company faces medium liquidity risk due to negative free cash flow and a current ratio near 1.0, while dilution risk is assessed as low, with no recent or disclosed share issuance activity. The absence of cash and equivalents further amplifies liquidity concerns.
Recent filings and transcripts indicate no material changes in the company's strategic direction or operational performance, with continued focus on cost control and capital efficiency.
- SCL.HNO generates strong returns on equity and assets, outperforming industry norms.
- The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.77.
- Free cash flow is negative, driven by high capital expenditures, indicating reinvestment in growth.
- Revenue and earnings are concentrated in a single segment, increasing operational risk.
- Liquidity is constrained, with no cash and equivalents and a current ratio of 1.13.
- Dilution risk is low, with no recent share issuance or dilutive events.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsDisposed 90exercise · 2026-05-11
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 550exercise · 2026-05-01
- VP and GM Surfactants NA · Restricted Stock Units → Restricted Stock UnitsAcquired 2 621grant · 2026-04-13
- VP and GM Surfactants-INT · Performance Shares → Common StockAcquired 1 429grant · 2026-04-13
- VP and GM Surfactants-INT · Stock Appreciation Right → Common StockAcquired 4 030 @ $52,46grant · 2026-04-13
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsAcquired 2 859grant · 2026-04-13
- VP and GM Surfactants NA · Performance Shares → Common StockAcquired 1 310grant · 2026-04-13
- VP and GM Surfactants NA · Stock Appreciation Right → Common StockAcquired 3 694 @ $52,46grant · 2026-04-13
- Director, President & CEO · Restricted Stock Units → Restricted Stock UnitsDisposed 857exercise · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Restricted Stock UnitsDisposed 429exercise · 2026-03-04
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Common StockDisposed 1 253exercise · 2026-03-03
- Director, President & CEO · Restricted Stock Units → Common StockDisposed 4 455exercise · 2026-03-03
- Director, President & CEO · Stock Appreciation Right → Common StockAcquired 57 241 @ $17,47grant · 2026-03-02
- EVP, Supply Chain · Performance Shares → Common StockAcquired 2 996grant · 2026-03-02
- EVP, Supply Chain · Stock Appreciation Right → Common StockAcquired 8 586 @ $17,47grant · 2026-03-02
- VP & GM Surfactants · Stock Appreciation Right → Common StockAcquired 7 155 @ $17,47grant · 2026-03-02
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsAcquired 4 495grant · 2026-03-02
- VP & GM Surfactants · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- V.P. and Gen'l. Mgr., Polymers · Stock Appreciation Right → Common StockAcquired 7 155 @ $17,47grant · 2026-03-02
- V.P. and Gen'l. Mgr., Polymers · Performance Shares → Common StockAcquired 2 497grant · 2026-03-02
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Restricted Stock UnitsAcquired 4 994grant · 2026-03-02
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SCL.HNO Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$37M
- Investment Managers · as of 2026-03-310,01 %$56M
- Investment Managers · as of 2024-06-300,01 %$281M
- Investment Managers · as of 2026-03-310,01 %$12M
- Institutional Investor · as of 2026-03-310,00 %$20M
- Investment Managers · as of 2026-03-310,00 %$23M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2025-12-310,00 %$122M
- Investment Managers · as of 2024-12-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$13M
- Investment Managers · as of 2026-03-310,00 %$26M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$45M
- Funds · as of 2026-03-310,00 %$9M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- VP and GM Surfactants-INT · Common StockOther 90 @ $52,58$5K · 2026-05-11
- VP and GM Surfactants-INT · Common StockOther 50 @ $52,58$3K · 2026-05-11
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- EVP, Supply Chain · Common StockOther 550 @ $50,33$28K · 2026-05-01
- EVP, Supply Chain · Common StockOther 162 @ $50,33$8K · 2026-05-01
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 429 @ $49,62$21K · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 149 @ $49,62$7K · 2026-03-04
- Director, President & CEO · Common StockOther 857 @ $49,62$43K · 2026-03-04
- Director, President & CEO · Common StockOther 252 @ $49,62$13K · 2026-03-04
- EVP, Supply Chain · Common StockOther 571 @ $49,62$28K · 2026-03-04
- EVP, Supply Chain · Common StockOther 168 @ $49,62$8K · 2026-03-04
- VP & GM Surfactants · Common StockOther 166 @ $49,62$8K · 2026-03-04
- VP & GM Surfactants · Common StockOther 571 @ $49,62$28K · 2026-03-04
- EVP, Supply Chain · Common StockOther 1 670 @ $48,98$82K · 2026-03-03
- EVP, Supply Chain · Common StockOther 490 @ $48,98$24K · 2026-03-03
- VP & GM Surfactants · Common StockOther 570 @ $48,98$28K · 2026-03-03
- VP & GM Surfactants · Common StockOther 1 670 @ $48,98$82K · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 434 @ $48,98$21K · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 1 253 @ $48,98$61K · 2026-03-03
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 33.1%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -0.9%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -0.2%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 2.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 6.3%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 11.4%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -8.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -7.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -6.9%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 8.1%Derived (calculated)
- Net margin (FY 2025-12-31): 2.0%Derived (calculated)
- Gross margin (FY 2025-12-31): 11.6%Derived (calculated)
- Return on equity (FY 2025-12-31): 3.8%Derived (calculated)
- Return on assets (FY 2025-12-31): 2.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.29xDerived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 0.2%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -6.8%Derived (calculated)
- Operating cash flow (annual): USD 147.88MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
- Operating income (annual): USD 78.55MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
- Net income (annual): USD 46.9MSEC XBRL filing